老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AbCellera Biologics

10.89
+0.43004.11%
盤後：10.87-0.0200-0.18%19:53 EDT
成交量：437.83萬
成交額：4,657.64萬
市值：35.28億
市盈率：-19.96
高：10.96
開：10.55
低：10.32
收：10.46
52周最高：12.58
52周最低：2.75
股本：3.24億
流通股本：2.21億
量比：1.44
換手率：1.98%
股息：- -
股息率：- -
每股收益(TTM):-0.5455
每股收益(LYR):-0.4902
淨資產收益率：-17.30%
總資產收益率：-10.39%
市淨率：3.94
市盈率(LYR):-22.22

資料載入中...

總覽公司新聞公告
2021/06/17

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/10

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/05/17

重要事件披露

8-K/A [Amend] - Current report
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/01

重要事件披露

8-K - Current report
2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/29

重要事件披露

8-K - Current report
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/28

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多